Evidence map›Paper›PMID 31024861›Full record

ArticleFrontiers in cellular and infection microbiology2019

The Vaginal and Urinary Microbiomes in Premenopausal Women With Interstitial Cystitis/Bladder Pain Syndrome as Compared to Unaffected Controls: A Pilot Cross-Sectional Study.

Kate V Meriwether, Zhenmin Lei, Rajbir Singh, Jeremy Gaskins, Deslyn T G Hobson, Venkatakrishna Jala

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04401176 phase2completednot on this mapstarted 2020, after this paper: background citation

A Randomized Trial of Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome

TypeinterventionalSponsorWalter Reed National Military Medical CenterRan2020 to 2023Enrolled58ConditionsInterstitial Cystitis, Bladder Pain SyndromeArmsHeparin & Alkalinized Lidocaine Bladder Instillation, Onabotulinum Toxin A
NCT05414305 phase2completednot on this mapstarted 2020, after this paper: background citation

The Female Microbiome in Patients Undergoing Bladder Instillation Therapy

TypeinterventionalSponsorWalter Reed National Military Medical CenterRan2020 to 2023Enrolled29ConditionsInterstitial Cystitis, Bladder Pain Syndrome, Microbial ColonizationArmsHeparin & Alkalinized Lidocaine Bladder Instillation
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. The Urobiome and Its Role in Overactive Bladder.International neurourology journal · 2022
    Article
  11. Review
  12. Biomarkers in the Light of the Etiopathology of IC/BPS.Diagnostics (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Urinary Microbiome: Yin and Yang of the Urinary Tract.Frontiers in cellular and infection microbiology · 2021
    Review
  18. Article
  19. [The role of the microbiome in urology].Der Urologe. Ausg. A · 2020
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kate V MeriwetherDepartment of Obstetrics and Gynecology, University of Louisville, Louisville, KY, United States.
Zhenmin LeiDepartment of Obstetrics and Gynecology, University of Louisville, Louisville, KY, United States.
Rajbir SinghDepartment of Microbiology and Immunology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, United States.
Jeremy GaskinsDepartment of Bioinformatics and Biostatistics, University of Louisville, Louisville, KY, United States.
Deslyn T G HobsonDepartment of Obstetrics and Gynecology, University of Louisville, Louisville, KY, United States.
Venkatakrishna JalaDepartment of Microbiology and Immunology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, United States.
University of Louisville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial cystitis/bladder pain syndrome (ICBPS) may be related to an altered genitourinary microbiome. Our aim was to compare the vaginal and urinary microbiomes between premenopausal women with ICBPS and unaffected controls. This cross-sectional study screened premenopausal women with an O'Leary-Sant questionnaire (ICBPS if score ≥6 on either index; controls <6 on both). Women completed questionnaires on health characteristics, pelvic floor symptoms (OABq, PFDI-20), body image (mBIS), and sexual function (PISQ-IR). Bacterial genomic DNA was isolated from vaginal and clean-catch urinary specimens; the bacterial 16 rRNA gene was sequenced and analyzed using the QIIME pipeline. We performed UniFrac analysis (β-diversity) and generated Chao1 estimator (richness) and Simpson index (richness and evenness) values. We analyzed 23 ICBPS and 18 non-ICBPS patients. ICBPS patients had increased vaginal deliveries, BMI, and public insurance as well as worsened OAB-q, PFDI-20, mBIS, and PISQ-IR domain scores.

Indexed as

MicrobiotaPremenopauseAdultCross-Sectional StudiesCystitis, InterstitialFemaleHumansMetagenomicsSurveys and QuestionnairesUrineVaginaYoung Adultbladder pain syndromegenitourinaryinterstitial cystitismicrobiomepainful bladderurinevagina

Identifiers

PMID31024861
PMCPMC6463740
OpenAlexW2937775676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.